Nia Therapeutics Develops Breakthrough Device to Restore Memory
The device is based on technology developed at Penn by Dr. Kahana and Dr. Rizzuto.
Avisi Technologies Raises $11M to Advance Glaucoma Treatment
The funding will support Avisi’s pivotal clinical trial for VisiPlate, a novel glaucoma treatment. device
Cogwear Named one of the Top Startups to Watch in 2025 by the Philadelphia Business Journal
Cogwear was recognized for its growth, funding and future projections.
REGENXBIO’s Gene Therapy Updates for Hunter Syndrome and DMD
REGENXBIO was co-founded by James M. Wilson, MD, PhD, the Rose H. Weiss Orphan Disease Center Director's Professor in Penn Medicine.
Michael Kahana Featured in NY Post for Memory Research
Michael Kahana was recently featured in the New York Post for his cutting-edge research in memory recall.
Penn Arts and Sciences’ MindCORE Neuroimaging Facility at Pennovation Works
The machine is the centerpiece of the new Neuroimaging Facility where scientists will study the mind-brain connection in-depth.
ToxiSense Develops Plant-Based Alternativeto Horseshoe Crab Blood
ToxiSense is developing a plant-based alternative to test for bacterial toxins in vaccines and medical devices, which could eliminate the current need for bloodletting of horseshoe crabs.
Nia Therapeutics Raises $8.5 Million
Penn spinout Nia Therapeutics recently raised $8.5 million in an equity financing round.
PCI Showcases Penn’s Neuroscience Innovation During JP Morgan Healthcare Conference
The program was well attended by professionals from across the globe in pharma, medtech and biotech industries and offered an incredible opportunity for networking and connection.
New ASSET Center
Penn Engineering’s newly formed ASSET (AI-enabled Systems: Safety, Explainablity and Trustworthiness) Center is part of Penn Engineering’s Innovation in Data Engineering & Science (IDEAS) Initiative.